This post was written by Zak Mir, a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator.
This post was written by Zak Mir, a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator.
This post was written by Zak Mir, a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator.
London’s results season is still underway with life insurers Aviva and L&G, bookmaker Entain, cybersecurity specialist Darktrace, and sausage roll maker Greggs all set to release results this week.
Contango Holdings Plc, the London listed natural resource development company, is pleased to advise that construction of a small-scale coke battery has been completed at the Lubu Coal Project in
Contango (CGO), the London listed natural resource development company, advised that construction of a small-scale coke battery has been completed at the Lubu Coal Project in Zimbabwe.
Synergia Energy (SYN) updated concerning the Cambay field. The company said its CEO visited several companies in Delhi and Ahmedabad concerning the Cambay field farm-out process.
Welcome to the weekly round-up from Share Talk, looking at the junior stock market, the AIM All-Share Index performed slightly worse than the FTSE 350, experiencing a 1.4% decline during
Contango Holdings Plc, the London-listed natural resource development company, announces its results for the six-month period ended 30 November 2022.
Belluscura (BELL), a medical device developer, announced that the X-PLOR portable oxygen concentrator is now marketed in the US through GoodRx, Inc. www.goodrx.com The X-PLOR will be the first medical
hVIVO (HVO), (formerly Open Orphan plc), a specialist contract research organisation, announced that it has signed a £6.8m contract with a leading pharmaceutical company based in Asia Pacific, to test
Poolbeg Pharma (POLB), a biopharmaceutical company, announced that it has acquired an exclusive licence from InsuCaps Limited, a sister company of AnaBio Technologies, to use InsuCaps’ patented microencapsulation and nanoencapsulation